These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pseudolymphoma induced by diphenylhydantoin. Gams RA J Pediatr; 1970 Dec; 77(6):1100-1. PubMed ID: 5486632 [No Abstract] [Full Text] [Related]
3. [3 cases of malignant lymphoma or pseudolymphoma in epileptics treated with diphenylhydantoin]. Alberto P; Cougn R; Maurice P; Weber J Schweiz Med Wochenschr; 1971 Dec; 101(49):1773-4. PubMed ID: 5140914 [No Abstract] [Full Text] [Related]
4. [A case of diphenylhydantoin-induced pseudo-pseudolymphoma (author's transl)]. Matsuo T; Matsumoto A; Miyasaki K Nihon Naika Gakkai Zasshi; 1977 Mar; 66(3):317-21. PubMed ID: 559053 [No Abstract] [Full Text] [Related]
5. [Case of "exanthematous pseudolymphoma" due to diphenylhydantoin hypersensitivity with a transitory immunologic deficit]. Vellucci A; Galanti G; Pezzella B; De Longis P; Colacecchi C Clin Ter; 1980 Jul; 94(2):229-37. PubMed ID: 7449346 [No Abstract] [Full Text] [Related]
6. Localized cutaneous pseudolymphoma associated with phenytoin therapy: a case report. Adams JD Australas J Dermatol; 1981 Apr; 22(1):28-9. PubMed ID: 7259668 [No Abstract] [Full Text] [Related]
7. Phenytoin-induced pseudolymphoma. A report of a case and review of the literature. Harris DW; Ostlere L; Buckley C; Whittaker S; Sweny P; Rustin MH Br J Dermatol; 1992 Oct; 127(4):403-6. PubMed ID: 1419762 [TBL] [Abstract][Full Text] [Related]
8. Phenytoin-induced pseudolymphoma: reevaluation using modern molecular biology techniques. Jeng YM; Tien HF; Su IJ Epilepsia; 1996 Jan; 37(1):104-7. PubMed ID: 8603615 [TBL] [Abstract][Full Text] [Related]
15. An unusual dual hypersensitivity reaction induced by diphenylhydantoin. Sisca TS Am J Hosp Pharm; 1973 May; 30(5):446-9. PubMed ID: 4267436 [No Abstract] [Full Text] [Related]
16. [A case of primary B-cell origin lymphoma of the stomach seen during diphenylhydantoin therapy (author's transl)]. Matoba K; Katsumata T; Kakei M; Kuwata H; Nakazawa H; Saigeni K; Okabe H; Chin S; Maekawa K; Katsuoka K; Oh-Ida M; Atari H Nihon Shokakibyo Gakkai Zasshi; 1981 Sep; 78(9):1797-802. PubMed ID: 6976466 [No Abstract] [Full Text] [Related]
17. Hematologic and immunologic aberrations in patients under diphenylhydantoin administration. Isobe T; Tomita M; Matsumoto J; Itoh T; Fujita T Nihon Ketsueki Gakkai Zasshi; 1983 Feb; 46(1):1-5. PubMed ID: 6858559 [No Abstract] [Full Text] [Related]
18. Diphenylhydantoin induced granulocytopenia following a seizure prophylaxis after a depressed skull fracture. Gabl M; Kostron H Zentralbl Neurochir; 1986; 47(4):339-41. PubMed ID: 3105193 [TBL] [Abstract][Full Text] [Related]
19. Pseudolymphoma with mycosis fungoides manifestations, hyperresponsiveness to diphenylhydantoin, and lymphocyte disregulation. Rosenthal CJ; Noguera CA; Coppola A; Kapelner SN Cancer; 1982 Jun; 49(11):2305-14. PubMed ID: 6978761 [TBL] [Abstract][Full Text] [Related]